KNSA vs PLD · P/E 53, rev $677.6M vs P/E 27, rev $2.30B
Kiniksa Pharmaceuticals Ltd (KNSA) versus Prologis Inc (PLD) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Prologis Inc (PLD) is a reit - industrial company listed on US.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Latest reported PLD revenue for 2026-03-31 was $2.30B. Net income was $982.0M. Revenue was up 2.0% from 2025-12-31 to 2026-03-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
Not investment advice. Open the KNSA and PLD stock pages for the full models.
Not investment advice.